December 30, 2016

December 30, 2016

From free marketers to millennial ambassadors: Here are the Tampa Bay business people to watch in 2017 – Dec. 29
At Tampa's already crowded Moffitt offices, an $800-million expansion will include a new hospital wing, two research buildings, a clinical support building and additional outpatient facilities. Imagine the role these two mega-medical brands will play here in the future. 

Power 100: Tampa Bay’s most influential business leaders
Tampa Bay Business Journal – Dec. 28
Dr. Alan List, President and CEO, Moffitt Cancer Center

A Personalized Approach to Radiation Therapy
OncoTherapy Network – Dec. 27
Investigators at the Moffitt Cancer Center are reporting on a new approach that can individualize a cancer patient’s radiotherapy dose to their tumor radiosensitivity.

2016 Marked by Payer-Provider Collaborations
Managed Care Magazine – Dec. 27
In a three-year pilot project, Moffitt Cancer Center in Florida and UnitedHealthcare developed surgery and radiation-therapy bundled payments focusing on early-stage lung cancer.

Women uncertain about giving up annual cervical cancer screening
MedPage Today – Dec. 23
This study's findings may demonstrate more about clinicians' resistance to the new guidelines than that of patients, commented Hye Sook Chon, MD, of the Center for Women's Oncology at Moffitt Cancer Center in Tampa, Fla.

Researchers use mathematics to explain treatment resistance
MedicalXpress – Dec. 22
A collaborative team of researchers from Moffitt Cancer Center's Integrated Mathematical Oncology (IMO) Program, led by Alexander Anderson, Ph.D., and Oxford University's Department of Computer Science are using mathematical models to explain how bacteria and cancer cells exploit an evolutionary process known as bet-hedging to resist medical intervention.

Moffitt researchers create a model for personalized radiation therapy – Dec. 21
Cancer therapeutics is currently in the era of precision medicine – personalized medicine for individual patients based on their tumor biology. Precision medicine is generally drug-based and little emphasis is placed on radiation therapy that is often assumed to be a “one-size-fits-all” treatment. Moffitt Cancer Center researchers have been instrumental is changing this assumption. Their study published today in The Lancet Oncology describes a novel genomics model that allows a personalized approach to radiation therapy.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.